Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for bulky locally advanced cervical cancer
ChiCTR1900023257Phase 4Not yet recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cisplatin in Cervical Cancer (CC) (2 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoints: Immediate efficacy evaluation and Progression-free survival. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1900023257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023257.